Ratings by Gabelli (Kevin Kedra)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/27/2021 | Iterum Therapeutics | ITRM | Upgrade | Hold (Sell) |
0.63 (0.03) |
-95.24% | Details | |
| 6/17/2021 | Elanco Animal Health | ELAN | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2021 | Elanco Animal Health | ELAN | Upgrade | Buy (Hold) |
32.24 (24.03) |
-25.47% | Details | |
| 3/22/2021 | Elanco Animal Health | ELAN | Downgrade | Hold (Buy) |
31.09 (24.03) |
-22.71% | Details | |
| 1/15/2021 | Lexicon Pharmaceuticals | LXRX | Downgrade | Hold (Buy) |
8.05 (2.26) |
-71.93% | Details | |
| 11/18/2020 | Lexicon Pharmaceuticals | LXRX | Upgrade | Buy (Hold) |
1.29 (2.26) |
75.19% | Details | |
| 11/6/2020 | Bristol-Myers Squibb Co. | BMY | Downgrade | Hold (Buy) |
63.75 (55.51) |
-12.93% | Details | |
| 8/12/2020 | Zoetis Inc. | ZTS | Downgrade | Hold (Buy) |
156.93 (78.17) |
-50.19% | Details | |
| 5/7/2020 | Tetraphase Pharmaceuticals | TTPH | Upgrade | Hold (Sell) |
1.39 (2.20) |
58.27% | Details | |
| 3/17/2020 | Tetraphase Pharmaceuticals | TTPH | Downgrade | Sell (Hold) |
1.45 (2.20) |
51.72% | Details | |
| 1/24/2020 | Tetraphase Pharmaceuticals | TTPH | Downgrade | Hold (Buy) |
3.84 (1.45) |
-62.24% | Details | |
| 1/21/2020 | Iterum Therapeutics | ITRM | Downgrade | Sell (Hold) |
4.46 (0.03) |
-99.33% | Details | |
| 1/14/2020 | Elanco Animal Health | ELAN | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2020 | Nabriva Therapeutics AG | NBRV | Maintain | Hold (N/A) |
|
Details | ||
| 12/11/2019 | Lexicon Pharmaceuticals | lxrx | Downgrade | Hold (Buy) |
5.15 (2.26) |
-56.12% | Details | |
| 11/27/2019 | Bristol-Myers Squibb Co. CVR | BMY-R | New Coverage | Buy (N/A) |
2.13 () |
-100% | Details | |
| 11/7/2019 | Elanco Animal Health | ELAN | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2019 | Collegium Pharmaceutical | COLL | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2019 | Tetraphase Pharmaceuticals | TTPH | Upgrade | Buy (Hold) |
3.62 (2.20) |
-39.23% | Details | |
| 9/11/2019 | Lexicon Pharmaceuticals | LXRX | Upgrade | Buy (Hold) |
1.72 (5.15) |
199.42% | Details | |
| 5/7/2019 | Allergen | AGN | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2019 | Zoetis Inc. | ZTS | Downgrade | Hold (Buy) |
101.79 (78.17) |
-23.2% | Details | |
| 5/2/2019 | Nabriva Therapeutics AG | NBRV | Upgrade | Hold (Sell) |
2.17 (1.42) |
-34.56% | Details | |
| 3/27/2019 | Nabriva Therapeutics AG | NBRV | Downgrade | Sell (Hold) |
2.93 (2.17) |
-25.94% | Details | |
| 3/25/2019 | Lexicon Pharmaceuticals | LXRX | Upgrade | Hold (Sell) |
7.94 (1.72) |
-78.34% | Details | |
| 3/18/2019 | Tetraphase Pharmaceuticals | TTPH | Downgrade | Hold (Buy) |
1.30 (3.62) |
178.46% | Details | |
| 3/14/2019 | Lexicon Pharmaceuticals | LXRX | Downgrade | Sell (Hold) |
7.17 (7.94) |
10.74% | Details | |
| 2/5/2019 | Covetrus | CVET | New Coverage | Buy (N/A) |
0.00 (20.99) |
0% | Details | |
| 12/20/2018 | Melinta Therapeutics Inc. | MLNT | Downgrade | Hold (Buy) |
1.08 (4.63) |
328.7% | Details | |
| 11/9/2018 | Achaogen | AKAO | Downgrade | Hold (Buy) |
3.08 (0.11) |
-96.43% | Details | |
| 9/20/2018 | Elanco Animal Health | ELAN | New Coverage | Buy (N/A) |
0.00 (24.03) |
0% | Details |
